查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1592920

注射笔市场：按类型、应用、最终用户、适应症分类 - 2025-2030 年全球预测

Injection Pen Market by Type (Disposable, Reusable Pens), Application (Fertility, Growth Hormone Therapy, Insulin Delivery), End User, Indication - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年註射笔市场价值为366.7亿美元，预计到2024年将达到391.9亿美元，复合年增长率为7.79%，到2030年将达到620.2亿美元。

注射笔市场范围被定义为用于自行注射胰岛素、生长激素和生物製药等药物的医疗设备，为传统注射器提供了易于使用的替代品。该设备越来越受到关注，因为它需要解决糖尿病等慢性疾病，并透过提高准确性和便利性来促进治疗依从性。注射笔应用跨越多个治疗领域，主要集中在内分泌学、肿瘤学和自体免疫疾病，最终用途包括医院、诊所和居家照护场所，提高患者的独立性和依从性。

主要市场统计
基准年[2023] 366.7亿美元
预测年份 [2024] 391.9亿美元
预测年份 [2030] 620.2亿美元
复合年增长率（%） 7.79%

根据市场洞察，注射笔市场的推动因素包括慢性病盛行率上升、对微创给药设备的需求增加以及智慧笔技术进步带来的剂量准确性和病患监测的提高。对生物相似药的需求迅速增加以及製药公司和设备製造商之间不断扩大的合作伙伴关係也带来了商机。为了利用这些机会，公司可以专注于开发具有增强连接性和易于使用设计的笔，以满足人口老化和新兴市场监管核准的需求。

挑战包括先进注射笔的高价格、新兴市场的知名度低以及设备故障的潜在问题，这些可能会阻碍市场的成长。为了保持竞争力，公司面临克服监管障碍和确保设备生产的永续性的挑战。创新机会在于增强笔的数位接口，以便更好地与医疗保健系统集成，开发用于永续製造的环保材料，以及结合人工智能进行个性化药物输送。市场的竞争和不断发展的本质强调以患者为中心的解决方案和法规遵从性，以确保市场领先地位。促进与高科技公司的智慧笔创新合作，并透过强大的分销网络加强市场渗透，可以成为业务成长的策略路线。

市场动态：揭示快速发展的注射笔市场的关键市场洞察

供需的动态交互作用正在改变注射笔市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 慢性病盛行率上升，核准数量不断增加
    • 新兴经济体的有利报销和政府支持
    • 糖尿病患者越来越多地使用笔进行胰岛素注射
  • 市场限制因素
    • 与注射笔相关的高成本
  • 市场机会
    • 开发输送装置技术以满足对注射笔日益增长的需求
    • 加大研发投入
  • 市场挑战
    • 偏好其他治疗方法

波特五力：驾驭注射笔市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解注射笔市场的外部影响

外部宏观环境因素对注射笔市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解注射笔市场的竞争状况

对注射笔市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵注射笔市场厂商绩效评估

FPNV定位矩阵是评估注射笔市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

制定注射笔市场成功之路的策略分析与建议

对于旨在加强其在全球市场的影响力的公司来说，注射笔市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病盛行率不断上升，监管部门核准数量不断增加
      • 已开发国家的优势报销与政府支持
      • 用于糖尿病患者註射胰岛素的笔式应用程式正在兴起
    • 抑制因素
      • 与注射笔相关的高成本
    • 机会
      • 由于需求增加而开发输送装置技术
      • 加大研发投入
    • 任务
      • 更喜欢其他治疗方法
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章註射笔市场：依类型

  • 一次性的
  • 可重复使用的笔

第七章註射笔市场：依应用分类

  • 生育力
  • 生长激素荷尔蒙疗法
  • 胰岛素给药
  • 骨质疏鬆症

第八章註射笔市场：依最终用户分类

  • 居家护理
  • 医院/诊所

第九章註射笔市场表现

  • 过敏反应
  • 癌症
  • 心血管疾病
  • 糖尿病
  • 多发性硬化症
  • 类风湿性关节炎

第十章 南北美洲注射笔市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太注射笔市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东、非洲笔触笔市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Aptar Digital Health 与 SHL Medical 合作，透过改善连接性和患者体验来推动自行注射治疗
    • Eisai和 Nippon Medac 在日本推出 Metject 皮下注射笔，为类风湿性关节炎患者增加便利性和安全性
    • 赛诺菲印度公司推出了 Soliqua，这是一种糖尿病治疗药物，可改善肥胖成年人的血糖控制并降低低血糖的风险。
  • 战略分析和建议

公司名单

  • Amgen Inc.
  • Antares Pharma, Inc.
  • AstraZeneca plc
  • Bayer AG
  • Biocorp Production by Novo Nordisk
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Gerresheimer AG
  • Inolife Sciences Inc.
  • Insulet Corporation
  • Medtronic plc
  • Mylan NV
  • Nemera Development SA
  • Novartis AG
  • Novo Nordisk A/S
  • Owen Mumford Ltd.
  • Pfizer Inc.
  • Sanofi SA
  • SHL Medical AG
  • Taiyo Pharma Co., Ltd.
  • Terumo Corporation
  • Teva Pharmaceuticals Industries Ltd.
  • West Pharmaceutical Services, Inc.
  • Wockhardt Limited
  • Ypsomed AG
Product Code: MRR-43127F727987

The Injection Pen Market was valued at USD 36.67 billion in 2023, expected to reach USD 39.19 billion in 2024, and is projected to grow at a CAGR of 7.79%, to USD 62.02 billion by 2030.

The scope of the injection pen market encompasses its definition as a medical device used for the self-administration of medication, such as insulin, growth hormones, and biologics, offering user-friendly alternatives to traditional syringes. This device is gaining traction due to its necessity in addressing chronic diseases like diabetes, facilitating treatment adherence through improved accuracy and convenience. The application of injection pens spans multiple therapeutic areas, primarily focusing on endocrinology, oncology, and autoimmune diseases, while the end-use scope includes hospitals, clinics, and home care settings, enhancing patient independence and compliance.

KEY MARKET STATISTICS
Base Year [2023] USD 36.67 billion
Estimated Year [2024] USD 39.19 billion
Forecast Year [2030] USD 62.02 billion
CAGR (%) 7.79%

Market insights indicate that the injection pen market is experiencing growth driven by factors such as the rising prevalence of chronic diseases, increasing demand for minimally invasive drug delivery devices, and technological advances in smart pen technology, improving dosage precision and patient monitoring. Opportunities arise from the surge in demand for biosimilars and the expansion of partnerships between pharmaceutical companies and device manufacturers. To capitalize on these opportunities, companies could focus on developing pens with enhanced connectivity features and user-friendly designs, catering to an aging population's needs and regulatory approvals in emerging markets.

Challenges include the high cost of advanced injection pens, limited awareness in developing regions, and potential issues related to device malfunctions, which could hinder market growth. Companies face the task of overcoming regulatory hurdles and ensuring sustainability in device production to maintain competitiveness. Innovation opportunities lie in enhancing the pen's digital interface for better integration with healthcare systems, developing eco-friendly materials for sustainable manufacturing, and incorporating AI for personalized drug delivery. The market's nature is highly competitive and evolving, with an emphasis on patient-centric solutions and regulatory compliance to secure market leadership. Fostering collaborations with tech firms for smart pen innovations and enhancing market penetration through robust distribution networks could serve as strategic routes for business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Injection Pen Market

The Injection Pen Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of chronic diseases and growing number of regulatory approvals
    • Favorable reimbursement in developed economies and government support
    • Growing application pens by people with diabetes to administer insulin
  • Market Restraints
    • High cost associated with injection pens
  • Market Opportunities
    • Development of delivery device technology owing to rising injection pen demand
    • Growing investments toward research and development
  • Market Challenges
    • Preference towards other modes of treatment

Porter's Five Forces: A Strategic Tool for Navigating the Injection Pen Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Injection Pen Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Injection Pen Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Injection Pen Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Injection Pen Market

A detailed market share analysis in the Injection Pen Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Injection Pen Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Injection Pen Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Injection Pen Market

A strategic analysis of the Injection Pen Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Injection Pen Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., Antares Pharma, Inc., AstraZeneca plc, Bayer AG, Biocorp Production by Novo Nordisk, Eli Lilly and Company, F. Hoffmann-La Roche AG, Gerresheimer AG, Inolife Sciences Inc., Insulet Corporation, Medtronic plc, Mylan N.V., Nemera Development S.A., Novartis AG, Novo Nordisk A/S, Owen Mumford Ltd., Pfizer Inc., Sanofi S.A., SHL Medical AG, Taiyo Pharma Co., Ltd., Terumo Corporation, Teva Pharmaceuticals Industries Ltd., West Pharmaceutical Services, Inc., Wockhardt Limited, and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Injection Pen Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Disposable and Reusable Pens.
  • Based on Application, market is studied across Fertility, Growth Hormone Therapy, Insulin Delivery, and Osteoporosis.
  • Based on End User, market is studied across Homecare and Hospitals & Clinics.
  • Based on Indication, market is studied across Anaphylaxis, Cancer, Cardiovascular Diseases, Diabetes, Multiple Sclerosis, and Rheumatoid Arthritis.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases and growing number of regulatory approvals
      • 5.1.1.2. Favorable reimbursement in developed economies and government support
      • 5.1.1.3. Growing application pens by people with diabetes to administer insulin
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with injection pens
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of delivery device technology owing to rising injection pen demand
      • 5.1.3.2. Growing investments toward research and development
    • 5.1.4. Challenges
      • 5.1.4.1. Preference towards other modes of treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Injection Pen Market, by Type

  • 6.1. Introduction
  • 6.2. Disposable
  • 6.3. Reusable Pens

7. Injection Pen Market, by Application

  • 7.1. Introduction
  • 7.2. Fertility
  • 7.3. Growth Hormone Therapy
  • 7.4. Insulin Delivery
  • 7.5. Osteoporosis

8. Injection Pen Market, by End User

  • 8.1. Introduction
  • 8.2. Homecare
  • 8.3. Hospitals & Clinics

9. Injection Pen Market, by Indication

  • 9.1. Introduction
  • 9.2. Anaphylaxis
  • 9.3. Cancer
  • 9.4. Cardiovascular Diseases
  • 9.5. Diabetes
  • 9.6. Multiple Sclerosis
  • 9.7. Rheumatoid Arthritis

10. Americas Injection Pen Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Injection Pen Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Injection Pen Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Aptar Digital Health and SHL Medical partnership to enhance self-injectable therapies through enhanced connectivity and patient experience
    • 13.3.2. Eisai and nippon medac launch Metoject Subcutaneous Injection Pen in Japan to enhance convenience and safety for rheumatoid arthritis patients
    • 13.3.3. Sanofi India launched Soliqua, a daily diabetes injection pen targeting obese adults to improve glycaemic control and reduce hypoglycemia risk
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amgen Inc.
  • 2. Antares Pharma, Inc.
  • 3. AstraZeneca plc
  • 4. Bayer AG
  • 5. Biocorp Production by Novo Nordisk
  • 6. Eli Lilly and Company
  • 7. F. Hoffmann-La Roche AG
  • 8. Gerresheimer AG
  • 9. Inolife Sciences Inc.
  • 10. Insulet Corporation
  • 11. Medtronic plc
  • 12. Mylan N.V.
  • 13. Nemera Development S.A.
  • 14. Novartis AG
  • 15. Novo Nordisk A/S
  • 16. Owen Mumford Ltd.
  • 17. Pfizer Inc.
  • 18. Sanofi S.A.
  • 19. SHL Medical AG
  • 20. Taiyo Pharma Co., Ltd.
  • 21. Terumo Corporation
  • 22. Teva Pharmaceuticals Industries Ltd.
  • 23. West Pharmaceutical Services, Inc.
  • 24. Wockhardt Limited
  • 25. Ypsomed AG

LIST OF FIGURES

  • FIGURE 1. INJECTION PEN MARKET RESEARCH PROCESS
  • FIGURE 2. INJECTION PEN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INJECTION PEN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INJECTION PEN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INJECTION PEN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INJECTION PEN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INJECTION PEN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INJECTION PEN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INJECTION PEN MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INJECTION PEN MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL INJECTION PEN MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL INJECTION PEN MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES INJECTION PEN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES INJECTION PEN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. INJECTION PEN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. INJECTION PEN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INJECTION PEN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INJECTION PEN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INJECTION PEN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INJECTION PEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INJECTION PEN MARKET DYNAMICS
  • TABLE 7. GLOBAL INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INJECTION PEN MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INJECTION PEN MARKET SIZE, BY REUSABLE PENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INJECTION PEN MARKET SIZE, BY FERTILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INJECTION PEN MARKET SIZE, BY GROWTH HORMONE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INJECTION PEN MARKET SIZE, BY INSULIN DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INJECTION PEN MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INJECTION PEN MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INJECTION PEN MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INJECTION PEN MARKET SIZE, BY ANAPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INJECTION PEN MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INJECTION PEN MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INJECTION PEN MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL INJECTION PEN MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL INJECTION PEN MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS INJECTION PEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES INJECTION PEN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 193. INJECTION PEN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. INJECTION PEN MARKET, FPNV POSITIONING MATRIX, 2023